Stockreport

Why Is Nanocap Immuneering Stock Trading Higher On Friday? [Yahoo! Finance]

Immuneering Corporation - Class A  (IMRX) 
PDF from the first five patients treated with IMM-1-104 in combination with modified gemcitabine/nab-paclitaxel in first-line pancreatic cancer as part of its ongoing Phase [Read more]